"Mercy Iowa City is an acute care hospital and regional referral center for southeast Iowa."

During the past decade, Mercy Hospital conducted 0 clinical trials. In the 10-year time frame, 0 clinical trials started and 1 clinical trials were completed, i.e. on average, 0% percent of trials that started reached the finish line to date. In the past 5 years, 0 clinical trials started and 0 clinical trials were completed. i.e. 0% of trials that started reached the finish line.

According to Clinical.Site data, the most researched conditions in "Mercy Hospital" are "Pulmonary Arterial Hypertension" (3 trials). Many other conditions were trialed in "Mercy Hospital" in a lesser frequency.

Most popular intervention types in "Mercy Hospital" are "Drug" (3 trials). Other intervention types were less common.

The name of intervention was led by "iloprost" (1 trials), "iloprost (5 µg)" (1 trials), "inhaled prostacyclin" (1 trials), "oral ERA" (1 trials) and "oral PDE5 inhibitors" (1 trials). Other intervention names were less common.

The vast majority of trials in "Mercy Hospital" are 3 trials for "All" genders.

Currently, there are NaN active trials in "Mercy Hospital". undefined are not yet recruiting, undefined are recruiting, undefined are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 3 completed trials in Mercy Hospital, undefined suspended trials, and undefined terminated clinical trials to date.

Out of the total trials that were conducted in Mercy Hospital, 0 "Phase 1" clinical trials were conducted, 0 "Phase 2" clinical trials and 2 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 0 trials, and there were also 0 trials that are defined as “Not Applicable".